Pretransplant frequency of donor-specific, IFN-gamma-producing lymphocytesis a manifestation of immunologic memory and correlates with the risk of posttransplant rejection episodes
Ps. Heeger et al., Pretransplant frequency of donor-specific, IFN-gamma-producing lymphocytesis a manifestation of immunologic memory and correlates with the risk of posttransplant rejection episodes, J IMMUNOL, 163(4), 1999, pp. 2267-2275
While matching for MHC Ags improves renal allograft survival, closely match
ed grafts sometimes fail due to rejection, and poorly matched allografts ar
e often well tolerated by the recipient. The severity of the rejection proc
ess may partially depend on the presence of environmentally primed T cells
in the recipient that cross-react with donor Ags, To test for the presence
of primed, donor-specific T cells in humans before transplantation, we used
an enzyme-linked immunospot assay for detection of allospecific cytokines
produced by individual human PBLs, We demonstrate that this approach detect
s cytokine production at single cell resolution and detects production of I
FN-gamma only when there is defined immunologic priming, thus representing
a measure of primed donor-specific immunity. Because the environmental Ag e
xposure of the recipient is not a function of the HLA mismatch between dono
r and potential recipient, the number of HLA mismatches may not correlate w
ith the frequency of pretransplant, donor-specific IFN-gamma-producing PBLs
, Studies of donor-specific IFN-gamma-producing lymphocytes in a cohort of
patients being evaluated for renal transplantation corroborated this hypoth
esis. Moreover, for recipients of both living and cadaver renal allografts,
the pretransplant frequency of donor-specific memory cells correlated with
the posttransplant risk of developing acute rejection episodes. This impro
ved ability to define the strength of the allospecific immune response by e
nzyme-linked immunospot assay may allow improved pairing of recipients with
donors and identification of kidney allograft donor-recipient pairs at hig
h risk for acute rejection, thus permitting targeted interventions aimed at
prolonging graft survival.